COMPANY DESCRIPTION
Ashland is a global, consumer market-focused additives and specialty ingredients company that is responsibly solving for a better world. Ashland’s pharmaceutical business is core to the company’s organic growth. As such, we’re focusing resources on high value applications to meet customer priorities. In addition to our commitment to pharmaceuticals and our foundational expertise, we offer the broadest range of excipients to compose effective oral solid dosage (OSD) and injectable pharmaceuticals.
TECHNICAL SERVICES
Ashland’s pharma business is supported globally by eight research and development labs located in the US, Latin America, Europe, and India, including four global centers of excellence.
FACILITIES
Ashland’s nine pharmaceutical ingredient manufacturing sites are in the US, Netherlands, France, Belgium, and Ireland.
MAJOR PRODUCTS/SERVICES
Ashland’s pharma business is well known for acetylenics, cellulosics, and film coatings, and our polymers have a rich and diverse history supporting active pharmaceutical ingredient delivery. Deploying resources to build on our existing high impact and high value technologies, we are widening our portfolio of cellulose-based polymers (HPMC, HPC, CMC, HEC, EC), growing our excipient portfolio for injectables/biologics and medical devices, including the possibility for customization, and we’re focusing on film coatings that live up to customer needs.
MARKETS SERVED
Our oral solid dosage and liquid dosage ingredients include controlled release agents, coatings, disintegrants, binders, rheology modifiers, and our expanding list of injectable excipient ingredients includes solubilizers, stabilizers, drug carriers, and other polymers used in long-acting formulations and medical devices. These comprise Ashland’s pharma portfolio, and it is the diamond at the center of Ashland.